Cart
sales@molnova.com
AZD3759 hydrochloride
CAS No. 1626387-81-2
AZD3759 hydrochloride( —— )
Catalog No. M18097 CAS No. 1626387-81-2
AZD3759 (hydrochloride) is an effective, orally active and central nervous system-penetrant?EGFR?inhibitor.
AZD3759 (hydrochloride) is an effective, orally active and central nervous system-penetrant?EGFR?inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | Get Quote |
|
| 5MG | 61 | Get Quote |
|
| 10MG | 88 | Get Quote |
|
| 25MG | 152 | Get Quote |
|
| 50MG | 268 | Get Quote |
|
| 100MG | 442 | Get Quote |
|
| 500MG | 1008 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAZD3759 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZD3759 (hydrochloride) is an effective, orally active and central nervous system-penetrant?EGFR?inhibitor.
-
DescriptionAZD3759 (hydrochloride) is an effective, orally active and central nervous system-penetrant?EGFR?inhibitor. At Km?ATP concentrations, the?IC50s are 0.2/0.3/0.2 nM for EGFR (L858R)/EGFR (wt)/EGFR (exon 19Del).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEGFR (exon 19De)| EGFR (L858R)| EGFR (wt)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1626387-81-2
-
Formula Weight496.36
-
Molecular FormulaC22H24Cl2FN5O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zeng Q, et al. J Med Chem. 2015 Oct 22;58(20):8200-15.
molnova catalog
related products
-
Methyl ganoderenate ...
Methyl ganoderenate D is a natural product for research related to life sciences.
-
Ethoxylated hydrogen...
Ethoxylated hydrogenated castor oil is a combination of synthetic polyethylene glycol (PEG) with natural castor oil.
-
Fosravuconazole L-ly...
FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
